These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 8495775

  • 21. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
    Mann DR, Gould KG, Smith MM, Duffey T, Collins DC.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
    [Abstract] [Full Text] [Related]

  • 22. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
    Bhasin S, Yuan QX, Steiner BS, Swerdloff RS.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
    [Abstract] [Full Text] [Related]

  • 23. Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis).
    Weinbauer GF, Göckeler E, Nieschlag E.
    J Clin Endocrinol Metab; 1988 Aug; 67(2):284-90. PubMed ID: 3292557
    [Abstract] [Full Text] [Related]

  • 24. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
    Bagatell CJ, McLachlan RI, de Kretser DM, Burger HG, Vale WW, Rivier JE, Bremner WJ.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
    [Abstract] [Full Text] [Related]

  • 25. Acute and chronic effects of a gonadotrophin-releasing hormone antagonist on pituitary and testicular function in monkeys.
    Bint Akhtar F, Weinbauer GF, Nieschlag E.
    J Endocrinol; 1985 Mar; 104(3):345-54. PubMed ID: 3882872
    [Abstract] [Full Text] [Related]

  • 26. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA, Yeung CH, Nieschlag E.
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Is high dosage testosterone an effective male contraceptive agent?
    Matsumoto AM.
    Fertil Steril; 1988 Aug; 50(2):324-8. PubMed ID: 3396702
    [Abstract] [Full Text] [Related]

  • 30. Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis).
    Weinbauer GF, Surmann FJ, Akhtar FB, Shah GV, Vickery BH, Nieschlag E.
    Fertil Steril; 1984 Dec; 42(6):906-14. PubMed ID: 6389185
    [Abstract] [Full Text] [Related]

  • 31. Spermatogenesis in men treated with injections of medroxyprogesterone acetate combined with testosterone enanthate.
    Frick J, Danner C, Kunit G, Joos H, Köhle R.
    Int J Androl; 1982 Jun; 5(3):246-52. PubMed ID: 7118265
    [Abstract] [Full Text] [Related]

  • 32. Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.
    Moltz L, Römmler A, Post K, Schwartz U, Hammerstein J.
    Contraception; 1980 Apr; 21(4):393-413. PubMed ID: 6771095
    [Abstract] [Full Text] [Related]

  • 33. Suppression of spermatogenesis in a nonhuman primate (Macaca fascicularis) by concomitant gonadotropin-releasing hormone antagonist and testosterone treatment.
    Weinbauer GF, Surmann FJ, Nieschlag E.
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):138-46. PubMed ID: 3544633
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone.
    Behre HM, Kliesch S, Lemcke B, von Eckardstein S, Nieschlag E.
    Hum Reprod; 2001 Dec; 16(12):2570-7. PubMed ID: 11726576
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
    Linde R, Doelle GC, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D.
    N Engl J Med; 1981 Sep 17; 305(12):663-7. PubMed ID: 6267464
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.